Clinical Study on the Treatment of Advanced Recurrent Tumors With Anticancer Mouse Characteristic Human Neutrophils

NCT06240767 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Solid Tumor, Adult
Advanced Cancer

Interventions

BIOLOGICAL: Granulocyte infusion

Sponsor

Wuxi People's Hospital